Modeling of Production Industrial Process of the Drug Flocalin and Search of its Optimally Effective Dose for Treatment of Heart Diseases

Gespeichert in:

Bibliographische Detailangaben
Datum:	2013
Hauptverfasser:	R. B. Strutynskyi, O. O. Moibenko, V. A. Chebanov, Yu. Horobets
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	2013
Schriftenreihe:	Science and innovation
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000740770
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

The influence of activation of the atp-sensitive potassium channels by flocalin on the function of the cardiovascular system
von: R. B. Strutynskyi, et al.
Veröffentlicht: (2013)

Influence of flocalin on development of apoptosis and necrosis at anoxia-reoxygenation of culture rats neonatal cardiomyocytes
von: R. B. Strutynskyi, et al.
Veröffentlicht: (2013)

Drug flurenisid as an immunomodulator for the treatment of orphan diseases
von: M. M. Kovalenko
Veröffentlicht: (2017)

Current aspects of coronary heart disease diagnosis and treatment
von: O. M. Korzh
Veröffentlicht: (2020)

Biochemical mechanisms of KATP channels opener flocalin (medical form) cardioprotective action at ischemia–reperfusion of myocardium
von: R. B. Strutynskyi, et al.
Veröffentlicht: (2013)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
von: O. A. Panibratiuk, et al.
Veröffentlicht: (2020)

Use of combined nucleotide drug in treatment of ophthalmic manifestations of Sjogren&#039;s disease
von: D. M. Miroshnik
Veröffentlicht: (2020)

Features of cardiohaemodynamics of patients with ischemic heart disease and arterial hypertension when the amlodipine included in complex treatment of chronic heart failure
von: Yu. Ilikchiieva
Veröffentlicht: (2017)

Cardiomyocite hibernation and hepatization in ishemic heart disease
von: Yu. Kyiak, et al.
Veröffentlicht: (2015)

Dose enhancement effect of anticaner drugs associated with increased temperature in vitro
von: Istomin, Yu.P., et al.
Veröffentlicht: (2008)

Determination of leeptin level in patients with ischemic heart disease after surgical myocardial revascularization at the stage of restoration treatment
von: O. V. Kolodenko
Veröffentlicht: (2017)

Optimal control strategy for the administration of the third vaccine dose in the treatment of pandemic COVID-19
von: I. Khaloufi, et al.
Veröffentlicht: (2023)

Features of the course of the chronic rheumatic heart disease in modern conditions
von: O. O. Yakymenko, et al.
Veröffentlicht: (2019)

The clinical value and characteristic of parameters of lipid, carbohydrate metabolism, structural and functional parameters of the heart under the influence of standard treatment of patients with ischemic heart disease and arterial hypertension combined w
von: O. M. Radchenko, et al.
Veröffentlicht: (2012)

Survival predictors in elderly patients with chronic ischemic heart disease
von: A. L. Filipiuk, et al.
Veröffentlicht: (2012)

Chronic rheumatic heart disease and environmental pollution degree of atmosphere
von: G. S. Taktashov
Veröffentlicht: (2016)

Generalized optimization of drug transport in tumors
von: D. A. Kliushyn, et al.
Veröffentlicht: (2020)

Influence of flocalin and diltiazem on ion regulatory function under condions of hypoxic nephropathy
von: A. I. Hozhenko, et al.
Veröffentlicht: (2014)

Influence of dry carbon dioxide baths and interference therapy on endothelial dysfunction in complex treatment of patients with ischemic heart disease and coronary syndrome Kh
von: E. O. Penina
Veröffentlicht: (2016)

Models of development and compensation of hypoxic conditions under ischemic heart disease
von: T. A. Semchyk
Veröffentlicht: (2017)

The role of microelementosis in pathogenesis of respiratory disorders at chronic rheumatic heart disease
von: G. S. Taktashov
Veröffentlicht: (2015)

Descamed endotheliocytes and stages of their dergradation in blood in patients with iscemic heart disease
von: A. E. Pavlega, et al.
Veröffentlicht: (2020)

The experimental investigation of fibrinolytic system under the influence of flocalin in conditions of acute hypoxic kidney injury
von: A. I. Gozhenko, et al.
Veröffentlicht: (2017)

Dynamics of clinical and functional indexes of cardiorespiratory system at the use of nicorandil in the treatment of patients with bronchial asthma in combination with coronary heart disease I-II FS
von: N. A. Matsehora, et al.
Veröffentlicht: (2017)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
von: Vtorushin, S.V., et al.
Veröffentlicht: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
von: S. V. Vtorushin, et al.
Veröffentlicht: (2014)

The influence of antioxidant therapy on lipid peroxidation and antioxidant protection in ischemic heart disease
von: E. A. Pavlova
Veröffentlicht: (2017)

Hypertensive heart disease in the adult population evacuated from the exclusion zone, in the post- emergency period
von: O. A. Kapustynska, et al.
Veröffentlicht: (2017)

Optimization of targeted drug delivery from systems of microneedles
von: S. I. Liashko, et al.
Veröffentlicht: (2017)

Sanatorium rehabilitation of patients with coronary heart disease after surgical myocardial revascularization conjunction with osteoarthritis
von: K. D. Babov, et al.
Veröffentlicht: (2015)

New approaches to the treatment of neurodegenerative diseases
von: M. V. Skok
Veröffentlicht: (2018)

Study of asymmetric dimethylarginine level in patients with ischemic heart disease without coronary atherosclerotic lesion
von: D. M. Sebov, et al.
Veröffentlicht: (2015)

New fluorine-containing openers of atp-sensitive potassium channels flokalin and tioflokalin inhibit calcium-induced mitochondrial pore opening in rat hearts
von: N. A. Strutynska, et al.
Veröffentlicht: (2013)

Optimal control of drug delivery from microneedles systems
von: S. I. Ljashko, et al.
Veröffentlicht: (2018)

Preoperative verification of comorbidity in patients with high-risk coronary heart disease on the eve of surgical myocardial revascularization
von: O. K. Hohaieva
Veröffentlicht: (2021)

Rationale for the differentiated appointment of vazoactive preparations in the treatment of patients with ischemic heart disease in combination with arterial hypertension dependent on the degree of pulmonary hypertension and / or the stage of chronic hear
von: N. A. Matsehora, et al.
Veröffentlicht: (2017)

Results of clinical application of thermoelectricdevice for the treatment of skin diseases
von: L. I. Anatychuk, et al.
Veröffentlicht: (2018)

Results of clinical application of thermoelectricdevice for the treatment of skin diseases
von: L. I. Anatychuk, et al.
Veröffentlicht: (2018)

Concomitant coronary heart disease as a factor in reducing the quality of life of patients with chronic pancreatitis
von: L. S. Babinets, et al.
Veröffentlicht: (2019)

The changes in the level of cytokines, glomerotubular markers, cardiohemodynamics in chronic heart failure and its combination with kidney disease
von: P. G. Kravchun, et al.
Veröffentlicht: (2012)